Timely reports on clinical research, legislative updates and product launches, from the editors of Review of Optometry and RCCL. Stories post each weekday morning.
The alpha-1 antagonist could help patients experiencing sympathetic overstimulation of Müller’s muscle, the presumed mechanism of this symptom, a small study suggests.
Although medication use contributed, the link remained even after accounting for side effects of antidepressant therapy. Also, Black participants had a disproportionately greater association.
A small case series observed this finding in patients with macular telangiectasia, AMD, diabetic retinopathy and scarring, as well as in eyes experiencing mechanical stress and fluid resorption.
Recent research demonstrates how this more accessible technique can effectively spot disease progression, enhancing clinicians’ predictive capabilities and guiding intervention milestones.
Researchers emphasize that neutralizing optical distortions is key to reliable vessel measurements, especially in studies of myopia and systemic health biomarkers.
New research shows highly myopic eyes that developed this complication were also more likely to have vitreomacular traction, retinal arteriolar traction and greater axial length.
The metrics and anatomical parameters obtained from almost 5,000 individuals could provide more precise cut-off values of healthy eyes and help train learning models.
Researchers were pleasantly surprised to find that these patients fared better than primary cataract surgery patients, given the absence of a posterior capsular barrier in a second procedure.
A study involving over 18,000 patients with the condition found that by 36 months, 19% progressed to neovascular AMD, which doubled the risk of exudative conversion in the fellow eye.
Data reveals a 27.9% prevalence among this patient population, emphasizing the need for greater awareness and monitoring of its impact on vision health.
New research reveals that these patients have a shorter axial length, steeper cornea and thicker macula, and calls for ongoing efforts to assess the long-term impact on visual outcomes.
Researchers found that increased age, female sex, steroids at initial visit and stromal involvement were each linked with higher odds of developing further problems.
At baseline, patients who experienced good outcomes on ranibizumab therapy tended to have higher vascular densities in the superficial and deep capillary plexuses and smaller FAZ areas.
Absence of PVD, Black race, Hispanic ethnicity, diabetic retinopathy and CRVO vs. BRVO incidents are all linked to a higher likelihood. The findings emphasize the importance of early detection and monitoring.
Understanding associations between this medication use and the thinning of retinal regions could serve as an early diagnostic indicator for retinal toxicity.
Researchers show a disproportionate impact on girls and East Asian populations in a new study, and they urge swift action to address this public health burden.
Emmetropes had longer tear break-up times and no evidence of ocular surface disease in a recent large study. Greater screen use is a potential culprit.